{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T03:41:32Z","timestamp":1783395692722,"version":"3.54.6"},"reference-count":45,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"HHS | National Institutes of Health","doi-asserted-by":"publisher","award":["5R01AI146078"],"award-info":[{"award-number":["5R01AI146078"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["MR\/S00291X\/1"],"award-info":[{"award-number":["MR\/S00291X\/1"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2022,6,21]]},"abstract":"<jats:p>\n            Methicillin-resistant\n            <jats:named-content content-type=\"genus-species\">Staphylococcus aureus<\/jats:named-content>\n            (MRSA) strains are a leading cause of many invasive clinical syndromes, and pose treatment difficulties due to their\n            <jats:italic>in vitro<\/jats:italic>\n            resistance to most \u03b2-lactams on standard laboratory testing. A novel phenotype frequently identified in MRSA strains, termed \u2018NaHCO\n            <jats:sub>3<\/jats:sub>\n            -responsiveness\u2019, is a property whereby strains are susceptible\n            <jats:italic>in vitro<\/jats:italic>\n            to many \u03b2-lactams in the presence of NaHCO\n            <jats:sub>3<\/jats:sub>\n            .\n          <\/jats:p>","DOI":"10.1128\/aac.00252-22","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T13:04:52Z","timestamp":1652706292000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":9,"title":["The NaHCO\n            <sub>3<\/sub>\n            -Responsive Phenotype in Methicillin-Resistant Staphylococcus aureus (MRSA) Is Influenced by\n            <i>mecA<\/i>\n            Genotype"],"prefix":"10.1128","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8792-2061","authenticated-orcid":true,"given":"Selvi C.","family":"Ersoy","sequence":"first","affiliation":[{"name":"The Lundquist Institute, Torrance, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4055-2489","authenticated-orcid":true,"given":"Adhar C.","family":"Manna","sequence":"additional","affiliation":[{"name":"Department of Microbiology &amp; Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Proctor","sequence":"additional","affiliation":[{"name":"University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry F.","family":"Chambers","sequence":"additional","affiliation":[{"name":"UCSF School of Medicine, San Francisco, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewan M.","family":"Harrison","sequence":"additional","affiliation":[{"name":"Wellcome Sanger Institute, Hinxton, United Kingdom"},{"name":"Department of Medicine, University of Cambridge, Cambridge, United Kingdom"},{"name":"Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold S.","family":"Bayer","sequence":"additional","affiliation":[{"name":"The Lundquist Institute, Torrance, California, USA"},{"name":"The Geffen School of Medicine, University of California, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambrose","family":"Cheung","sequence":"additional","affiliation":[{"name":"Department of Microbiology &amp; Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000752"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68853-3"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00134-14"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1444-0903.2005.00978.x"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu043"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgar.2016.07.010"},{"key":"e_1_3_3_8_2","first-page":"133","article-title":"Treatment options for methicillin-resistant Staphylococcus aureus (MRSA) infection: where are we now?","volume":"2","author":"Edwards B","year":"2014","unstructured":"Edwards B, Andini R, Esposito S, Grossi P, Lew D, Mazzei T, Novelli A, Soriano A, Gould I. 2014. Treatment options for methicillin-resistant Staphylococcus aureus (MRSA) infection: where are we now? Jgar 2:133\u2013140.","journal-title":"Jgar"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2015.08.012"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2017.05.026"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00496-19"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2015.05.021"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv487"},{"key":"e_1_3_3_14_2","article-title":"Bicarbonate modulates delafloxacin activity against MDR Staphylococcus aureus and Pseudomonas aeruginosa","author":"Holland M","year":"2021","unstructured":"Holland M, Bjanes E, Nizet V, Dillon N. 2021. Bicarbonate modulates delafloxacin activity against MDR Staphylococcus aureus and Pseudomonas aeruginosa. J Antimicrob Chemother.","journal-title":"J Antimicrob Chemother"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.7b00194"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02445-19"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(80)80455-8"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.158.2.513-516.1984"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/161.6.1170"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/162.3.705"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02621-20"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.3390\/genes12111650"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1300118110"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.6b12565"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja0434376"},{"key":"e_1_3_3_26_2","first-page":"119","volume-title":"Antibacterials.","author":"Meisel JE","year":"2018","unstructured":"Meisel JE, Fisher JF, Chang M, Mobashery S. 2018. Allosteric inhibition of bacterial targets: an opportunity for discovery of novel antibacterial classes. p 119\u2013147. Antibacterials. Springer International Publishing."},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja5030657"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-019-0471-0"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02045-13"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.000610"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10091089"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023287"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/jb.171.2.874-879.1989"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.9.1307"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.3947\/ic.2013.45.2.117"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1078\/1438-4221-00192"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.5.1323-1336.2001"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11040462"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1086\/379022"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.02002-14"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.70.11.6887-6891.2004"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00308-15"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.9.5385-5392.2000"},{"key":"e_1_3_3_44_2","unstructured":"Hudzicki J. 2009. Kirby-Bauer disk diffusion susceptibility test protocol."},{"key":"e_1_3_3_45_2","volume-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard.","author":"Cockerill FR","year":"2012","unstructured":"Cockerill FR. 2012. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standard. Clinical and Laboratory Standards Institute (CLSI)."},{"key":"e_1_3_3_46_2","volume-title":"Performance standards for antimicrobial susceptibility testing.","author":"Weinstein MP","year":"2018","unstructured":"Weinstein MP, Patel JB, Campeau S, Eliopoulos GM, Galas MF, Humphries RM, Jenkins SG, Ii JSL, Limbago B, Mathers AJ, Mazzulli T, Patel R, Richter SS, Satlin M, Swenson JM, Zimmer BL. 2018. Performance standards for antimicrobial susceptibility testing. Clinical and Laboratory Standards Institute (CLSI)."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.00252-22","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aac.00252-22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T14:51:09Z","timestamp":1655823069000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/aac.00252-22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,21]]},"references-count":45,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6,21]]}},"alternative-id":["10.1128\/aac.00252-22"],"URL":"https:\/\/doi.org\/10.1128\/aac.00252-22","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,21]]},"assertion":[{"value":"2022-02-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00252-22"}}